Association between the scores on the general health questionnaire-28 and the saliva levels of 3-methoxy-4-hydroxyphenylglycol in normal volunteers

Biological Psychology

Volumn 73, Issue 2, 2006, Pages 209-211

  Li, G Y ^a   Ueki, H ^a   Yamamoto, Y ^a   Yamada, S ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

GHQ 28; Normal volunteers; Saliva MHPG

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL;

ADULT; AGED; ANXIETY; ARTICLE; CORRELATION ANALYSIS; FEMALE; GENERAL HEALTH QUESTIONNAIRE; HUMAN; INSOMNIA; MALE; MENTAL HEALTH; NERVE CELL; NORADRENERGIC NERVE; NORMAL HUMAN; PRIORITY JOURNAL; SALIVA LEVEL; SCORING SYSTEM; SEX DIFFERENCE; SOCIAL DISABILITY; VOLUNTEER;

ADULT; AGED; ANXIETY; AROUSAL; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; NOREPINEPHRINE; PERSONALITY INVENTORY; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; REFERENCE VALUES; SALIVA; SEX FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS; SOCIAL ADJUSTMENT; SOMATOFORM DISORDERS; STATISTICS; STATISTICS AS TOPIC;

EID: 33745933047     PISSN: 03010511     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsycho.2006.01.001     Document Type: Article

References (20)

1. Azorin J.M., Raucoules D., Valli M., Levy C., Lancon C., Luccioni J.M., and Tissot R. Plasma levels of 3-methoxy-4-hydroxyphenylglycol in depressed patients compared with normal controls. Neuropsychobiology 23 (1990) 18-24
2. Best N.R., Rees M.P., Barlow D.A., and Cowen P.J. Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology 17 (1992) 87-93
3. Carr V., Edwards J., and Prior M. Urinary MHPG, platelet 3H-imipramine binding and symptomatology in depression: an exploratory study of clinical heterogeneity. Biological Psychiatry 23 (1988) 560-574
4. Del Rio G., Velardo A., Zizzo G., Avogaro A., Cipolli C., DellaCasa L., Marrama P., and McDonardo I.A. Effect of estradiol on the sympathoadrenal response to mental stress in normal men. Journal of Clinical Endocrinology and Metabolism 79 (1994) 836-840
5. Drebing C.J., Freedman R., Waldo M., and Gerhardt G.A. Unconjugated methoxylated catecholamine metabolites in human saliva. Quantitation methodology and comparison with plasma levels. Biomedical Chromatography 3 (1989) 217-220
6. Forsman L., and Lundberg U. Consistency in catecholamine and cortisol excretion in males and females. Pharmacological Biochemical Behaviour 17 (1982) 555-562
7. Goldberg D.P. The detection of psychiatric illness by questionnaire. A technique for the identification and assessment of non-psychotic psychiatric illness. (Maudsley Monographs No. 21) (1972), Oxford University Press, London
8. Goldberg D.P., and Hillier V.F. A scaled version of the General Health Questionnaire. Psychological Medicine 9 (1979) 139-145
9. Leckman J.F., Maas J.W., Redmond D.E., and Heninger G.R. Effects of oral clonidine on plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) in men: Preliminary report. Life Science 26 (1980) 2179-2185
10. Li G.Y., Ueki H., Kawashima T., Sugataka K., Muraoka T., and Yamada S. Involvement of the noradrenergic system in performance on a continuous task requiring effortful attention. Neuropsychobiology 50 (2004) 336-340
11. Muscettola G., Potter W.Z., Pickar D., and Goodwin F.K. Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings. Archives of General Psychiatry 41 (1984) 337-342
12. Odink J., Van der Ploeg H.M., Van den Berc G.M.J., Van Kempen G.M., Bruinse H.W., and Louwerse E.S. Circadian and circatrigintan rhythms of biogenic aminoes in premenstrual syndrome (PMS). Psychosomatic Medicine 52 (1990) 346
13. Pliszka S.R., Rogeness G.A., and Medrano M.A. DBH, MHPG and MAO in children with depressive, anxiety and conduct disorders: relationship to diagnosis and symptom ratings. Psychiatry Research 24 (1988) 35-44
14. Reuster T., Rilke O., and Oehler J. High correlation between salivary MHPG and CSF MHPG. Psychopharmacology (Berl) 162 (2002) 415-418
15. Roy A., Jimerson D.C., and Pickar D. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test. American Journal of Psychiatry 143 (1986) 846-851
16. Scatton B., Loo H., Dennis T., Benkelfat C., Gay C., and Poirier-Littre M.F. Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression. Psychopharmacology (Berl) 88 (1986) 220-225
17. Sevy S., Papadimitriou G.N., Surmont D.W., Goldman S., and Mendlewicz J. Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects. Biological Psychiatry 25 (1989) 141-152
18. Uhde T.W., Boulenger J.P., Post R.M., Siever L.J., Vittone B.J., Jimerson D.C., and Roy-Byme P.P. Fear and anxiety: relationship to noradrenergic function. Psychopathology 17 Suppl. 3 (1984) 8-23
19. Yang R.K., Yehuda R., Holland D.D., and Knott P.J. Relationship between 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in saliva and plasma of healthy volunteers. Biological Psychiatry 42 (1997) 821-826
20. Yamada S., Yamauchi K., Yajima J., Hisadomi S., Maeda H., Toyomasu K., and Tanaka M. Saliva level of free 3-methoxy-4-hydroxyphenylglycol (MHPG) as a biological index of anxiety disorders. Psychiatry Research 93 (2000) 217-223